作者
Karen B Onel, Daniel B Horton, Daniel J Lovell, Susan Shenoi, Carlos A Cuello, Sheila T Angeles‐Han, Mara L Becker, Randy Q Cron, Brian M Feldman, Polly J Ferguson, Harry Gewanter, Jaime Guzman, Yukiko Kimura, Tzielan Lee, Katherine Murphy, Peter A Nigrovic, Michael J Ombrello, C Egla Rabinovich, Melissa Tesher, Marinka Twilt, Marisa Klein‐Gitelman, Fatima Barbar‐Smiley, Ashley M Cooper, Barbara Edelheit, Miriah Gillispie‐Taylor, Kimberly Hays, Melissa L Mannion, Rosemary Peterson, Elaine Flanagan, Nadine Saad, Nancy Sullivan, Ann Marie Szymanski, Rebecca Trachtman, Marat Turgunbaev, Keila Veiga, Amy S Turner, James T Reston
发表日期
2022/4
期刊
Arthritis & rheumatology
卷号
74
期号
4
页码范围
553-569
出版商
Wiley Periodicals, Inc.
简介
Objective
To provide updated guidelines for pharmacologic management of juvenile idiopathic arthritis (JIA), focusing on treatment of oligoarthritis, temporomandibular joint (TMJ) arthritis, and systemic JIA with and without macrophage activation syndrome. Recommendations regarding tapering and discontinuing treatment in inactive systemic JIA are also provided.
Methods
We developed clinically relevant Patient/Population, Intervention, Comparison, and Outcomes questions. After conducting a systematic literature review, the Grading of Recommendations Assessment, Development and Evaluation approach was used to rate the quality of evidence (high, moderate, low, or very low). A Voting Panel including clinicians and patients/caregivers achieved consensus on the direction (for or against) and strength (strong or conditional) of recommendations.
Results
Similar to those published in 2019, these JIA …
学术搜索中的文章
KB Onel, DB Horton, DJ Lovell, S Shenoi, CA Cuello… - Arthritis & rheumatology, 2022